Award
University of California, San Francisco 5R01EY028739-09
The Impact of the Herpes Zoster Vaccine on Herpes Zoster Ophthalmicus
Recipient
University of California, San Francisco
Award Amount
$606,466.00
Ceiling
$606,466.00
Awarded
June 11, 2026
Identifier
5R01EY028739-09
Research project evaluating the long-term effectiveness and safety of the Herpes Zoster vaccine in different populations to guide clinical and policy decisions.
Description
This project aims to assess the long-term effectiveness of the Herpes Zoster vaccine (Shingrix) in various populations, including immunocompromised individuals and those with a history of herpes zoster ophthalmicus. It involves analysis of incidence rates, vaccine coverage, safety, and efficacy to inform policy and clinical practice.